MTOR and leukemia: In recently published work [82], we examined the effects of dual TORC1/2 inhibition on various elements of the mTOR pathway in different AML cell lines and primary leukemia blasts from AML patients and compared them to the effects of the classic mTOR inhibitor rapamycin.